Global Point-Of-Care Or Rapid Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Point-Of-Care Or Rapid Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Point-Of-Care Or Rapid Diagnostics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Point-Of-Care Or Rapid Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Point-Of-Care Or Rapid Diagnostics include Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope


This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Point-Of-Care Or Rapid Diagnostics segment by Type

Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Point-Of-Care Or Rapid Diagnostics segment by Application

Hospital
Clinic
Independent Laboratories
Others
Point-Of-Care Or Rapid Diagnostics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Point-Of-Care Or Rapid Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales Estimates and Forecasts (2019-2030)
1.3 Point-Of-Care Or Rapid Diagnostics Market by Type
1.3.1 Intensive Care
1.3.2 Covid-19 Testing
1.3.3 Infectious Diseases Testing
1.3.4 Cardiac Markers Testing
1.3.5 Coagulation Testing
1.3.6 Others
1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size by Type
1.4.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Overview by Type (2019-2030)
1.4.2 Global Point-Of-Care Or Rapid Diagnostics Historic Market Size Review by Type (2019-2024)
1.4.3 Global Point-Of-Care Or Rapid Diagnostics Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Type (2019-2024)
1.5.2 Europe Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
2.2 Point-Of-Care Or Rapid Diagnostics Industry Drivers
2.3 Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
2.4 Point-Of-Care Or Rapid Diagnostics Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Point-Of-Care Or Rapid Diagnostics Revenue (2019-2024)
3.2 Global Top Players by Point-Of-Care Or Rapid Diagnostics Sales (2019-2024)
3.3 Global Top Players by Point-Of-Care Or Rapid Diagnostics Price (2019-2024)
3.4 Global Point-Of-Care Or Rapid Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Point-Of-Care Or Rapid Diagnostics Key Company Manufacturing Sites & Headquarters
3.6 Global Point-Of-Care Or Rapid Diagnostics Company, Product Type & Application
3.7 Global Point-Of-Care Or Rapid Diagnostics Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Point-Of-Care Or Rapid Diagnostics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue in 2023
3.8.3 2023 Point-Of-Care Or Rapid Diagnostics Tier 1, Tier 2, and Tier 3
4 Point-Of-Care Or Rapid Diagnostics Regional Status and Outlook
4.1 Global Point-Of-Care Or Rapid Diagnostics Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Point-Of-Care Or Rapid Diagnostics Historic Market Size by Region
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2019-2024)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Region (2019-2024)
4.2.3 Global Point-Of-Care Or Rapid Diagnostics Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Point-Of-Care Or Rapid Diagnostics Forecasted Market Size by Region
4.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2025-2030)
4.3.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Region (2025-2030)
4.3.3 Global Point-Of-Care Or Rapid Diagnostics Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Point-Of-Care Or Rapid Diagnostics by Application
5.1 Point-Of-Care Or Rapid Diagnostics Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Independent Laboratories
5.1.4 Others
5.2 Global Point-Of-Care Or Rapid Diagnostics Market Size by Application
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Overview by Application (2019-2030)
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Historic Market Size Review by Application (2019-2024)
5.2.3 Global Point-Of-Care Or Rapid Diagnostics Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Application (2019-2024)
5.3.2 Europe Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.1.5 Roche Recent Developments
6.2 Abbott
6.2.1 Abbott Comapny Information
6.2.2 Abbott Business Overview
6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.2.5 Abbott Recent Developments
6.3 Danaher
6.3.1 Danaher Comapny Information
6.3.2 Danaher Business Overview
6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.3.5 Danaher Recent Developments
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Comapny Information
6.4.2 Siemens Healthcare Business Overview
6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.4.5 Siemens Healthcare Recent Developments
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Comapny Information
6.5.2 Bio-Rad Laboratories Business Overview
6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments
6.6 BioMerieux
6.6.1 BioMerieux Comapny Information
6.6.2 BioMerieux Business Overview
6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.6.5 BioMerieux Recent Developments
6.7 Nova Biomedical
6.7.1 Nova Biomedical Comapny Information
6.7.2 Nova Biomedical Business Overview
6.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.7.5 Nova Biomedical Recent Developments
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Comapny Information
6.8.2 Thermo Fisher Scientific Business Overview
6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments
6.9 Quidel
6.9.1 Quidel Comapny Information
6.9.2 Quidel Business Overview
6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.9.5 Quidel Recent Developments
6.10 A. Menarini Diagnostics
6.10.1 A. Menarini Diagnostics Comapny Information
6.10.2 A. Menarini Diagnostics Business Overview
6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.10.5 A. Menarini Diagnostics Recent Developments
6.11 Becton Dickinson
6.11.1 Becton Dickinson Comapny Information
6.11.2 Becton Dickinson Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments
6.12 Biosurfit
6.12.1 Biosurfit Comapny Information
6.12.2 Biosurfit Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Comapny Information
6.13.2 Astrego Diagnostics Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments
6.14 Werfen
6.14.1 Werfen Comapny Information
6.14.2 Werfen Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments
6.15 Abionic
6.15.1 Abionic Comapny Information
6.15.2 Abionic Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Comapny Information
6.16.2 Palex Medical/Bülhmann Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments
6.17 Horiba Medical
6.17.1 Horiba Medical Comapny Information
6.17.2 Horiba Medical Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments
6.18 RAL
6.18.1 RAL Comapny Information
6.18.2 RAL Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments
6.19 Vircell
6.19.1 Vircell Comapny Information
6.19.2 Vircell Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments
6.20 Monlab
6.20.1 Monlab Comapny Information
6.20.2 Monlab Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments
6.21 Binding Site
6.21.1 Binding Site Comapny Information
6.21.2 Binding Site Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments
7 North America by Country
7.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Country
7.1.1 North America Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
7.1.3 North America Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030)
7.2 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country
7.2.1 North America Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country (2019-2024)
7.2.3 North America Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country
8.1.1 Europe Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
8.1.3 Europe Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030)
8.2 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country
8.2.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country (2019-2024)
8.2.3 Europe Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country
9.1.1 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
9.1.3 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country
9.2.1 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country
10.1.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
10.1.3 Latin America Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030)
10.2 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country
10.2.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country (2019-2024)
10.2.3 Latin America Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country
11.1.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
11.1.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country
11.2.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Point-Of-Care Or Rapid Diagnostics Value Chain Analysis
12.1.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
12.2 Point-Of-Care Or Rapid Diagnostics Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Point-Of-Care Or Rapid Diagnostics Distributors
12.2.3 Point-Of-Care Or Rapid Diagnostics Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings